Drug Shortage Report for AURALGAN
Report ID | 149033 |
Drug Identification Number | 02332477 |
Brand name | AURALGAN |
Common or Proper name | BENZOCAINE |
Company Name | PALADIN PHARMA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ANTIPYRINE BENZOCAINE |
Strength(s) | 54MG 14MG |
Dosage form(s) | SOLUTION |
Route of administration | OTIC OTIC |
Packaging size | 14mL |
ATC code | S02DA |
ATC description | OTHER OTOLOGICALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-02 |
Estimated end date | 2022-08-01 |
Actual end date | 2022-07-25 |
Shortage status | Resolved |
Updated date | 2022-07-26 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2022-07-26 | English | Compare |
v15 | 2022-07-25 | French | Compare |
v14 | 2022-07-25 | English | Compare |
v13 | 2022-07-25 | English | Compare |
v12 | 2022-02-02 | French | Compare |
v11 | 2022-02-02 | English | Compare |
v10 | 2022-02-02 | French | Compare |
v9 | 2022-02-02 | English | Compare |
v8 | 2022-01-14 | French | Compare |
v7 | 2022-01-14 | English | Compare |
v6 | 2021-12-28 | French | Compare |
v5 | 2021-12-28 | English | Compare |
v4 | 2021-12-14 | French | Compare |
v3 | 2021-12-14 | English | Compare |
v2 | 2021-11-10 | French | Compare |
v1 | 2021-11-10 | English | Compare |
Showing 1 to 16 of 16